Tower Research Capital (TRC)’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.3K | Buy |
74,053
+63,129
| +578% | +$79.5K | ﹤0.01% | 2438 |
|
|
2025
Q1 | $9.98K | Buy |
10,924
+3,572
| +49% | +$3.26K | ﹤0.01% | 3695 |
|
|
2024
Q4 | $11.7K | Buy |
7,352
+2,038
| +38% | +$3.24K | ﹤0.01% | 3686 |
|
|
2024
Q3 | $10.4K | Sell |
5,314
-33,787
| -86% | -$66.2K | ﹤0.01% | 3760 |
|
|
2024
Q2 | $64.1K | Buy |
39,101
+34,674
| +783% | +$56.9K | ﹤0.01% | 2907 |
|
|
2024
Q1 | $22.8K | Sell |
4,427
-16,507
| -79% | -$84.8K | ﹤0.01% | 2882 |
|
|
2023
Q4 | $120K | Buy |
20,934
+13,678
| +189% | +$78.4K | ﹤0.01% | 2507 |
|
|
2023
Q3 | $34.7K | Buy |
7,256
+385
| +6% | +$1.84K | ﹤0.01% | 2894 |
|
|
2023
Q2 | $29.2K | Buy |
6,871
+3,218
| +88% | +$13.7K | ﹤0.01% | 3024 |
|
|
2023
Q1 | $19K | Sell |
3,653
-5,634
| -61% | -$29.3K | ﹤0.01% | 3481 |
|
|
2022
Q4 | $58K | Sell |
9,287
-4,270
| -31% | -$26.7K | ﹤0.01% | 2234 |
|
|
2022
Q3 | $143K | Buy |
13,557
+10,489
| +342% | +$111K | ﹤0.01% | 2233 |
|
|
2022
Q2 | $17K | Sell |
3,068
-1,613
| -34% | -$8.94K | ﹤0.01% | 3948 |
|
|
2022
Q1 | $43K | Buy |
4,681
+2,021
| +76% | +$18.6K | ﹤0.01% | 2851 |
|
|
2021
Q4 | $40K | Buy |
2,660
+2,190
| +466% | +$32.9K | ﹤0.01% | 2940 |
|
|
2021
Q3 | $11K | Buy |
+470
| New | +$11K | ﹤0.01% | 4212 |
|